P3781
Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving PirfenidoneEvaluate the Effect of Diet on Gastrointestinal Adverse Events in Patients With IPF Treated With PirfenidonePirfenidone as Treatment of Skin Fibrosis in Systemic SclerosisEfficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary FibrosisThe Safety and Tolerability of Pirfenidone for BOS After HCTEvaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary FibrosisA Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and EfficacyNon-Interventional Study (NIS) Collecting Experiences For IPF in TaiwanTrial of Pirfenidone to Prevent Progression in Chronic Kidney DiseaseA Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus InfectionImpact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes
P4844
Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis.Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.Pirfenidone inhibits proliferation, arrests the cell cycle, and downregulates heat shock protein-47 and collagen type I in rat hepatic stellate cells in vitro.Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experiencePirfenidone—a ray of hope in oral sub mucous fibrosis.Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: does it take these two to tango?Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS.Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G₁ Cell Cycle ArrestThe antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitroIdiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient ManagementNegative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosisAcute Exacerbation of Idiopathic Pulmonary FibrosisPirfenidone inhibits epidural scar fibroblast proliferation and differentiation by regulating TGF-β1-induced Smad-dependent and -independent pathwaysCXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activationRetrospective Analysis of Medication Utilization and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis Treated With Nintedanib or PirfenidoneEffect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosisSystematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosisAssessment of 8-methosypsoralen, lomefloxacin, sparfloxacin, and Pirfenidone phototoxicity in Long-Evans rats
P921
Q61957299-7AF14B2D-4246-4900-A729-5DAC90B0452BQ62054002-770FB54A-B2A7-4E51-A741-A21FFA92BB65Q62812734-EABBA0AA-2EB3-4ABB-B017-70B7BA691463Q63229293-358625F9-C74C-463B-9E68-D61C81785EBAQ63333643-0F384626-B850-4234-903E-BA32CA522D82Q63397883-A4A2B4F3-7CAE-41D6-97F7-7A3A974BE329Q63570732-87D7AC98-C2D1-4BCE-B1EA-AB14E6D9889CQ63575285-25F1254E-1230-403C-A56B-1932005174EBQ63578122-731A7625-5F2E-493E-BFA8-2E0C792060EFQ63595877-9F7C8963-2D73-45B3-91FC-4689E50B4436Q63812010-58896951-1802-4061-8464-A8FF07206D46Q86251235-0BC44E69-AE99-4BBD-B68E-AE3095FAD151Q87930632-E65477E4-17F8-4D4E-B20B-C4B18493AD71Q89154165-D8C391B6-8212-468F-89EC-9EE03215CAA3
P4844
Q34984470-F0A37C3D-7753-4377-AED7-EC40E6CA9484Q38325422-FEF69B09-601C-4A29-9B6C-CFA470E32486Q38359491-95438C6A-247A-4960-9230-7725675D2615Q38366248-684323AB-C6E5-4880-B4F6-D7962FB39AAEQ38366438-7EBEC79D-F8DE-442B-BA9C-ADE552643C4FQ38903740-6115D229-DC78-434B-92B9-7F68094C9BB1Q41499477-7D0E4B14-2446-47D7-A0A9-FE9FE772020AQ41910552-2DC3A047-151C-4904-A301-C56DF0E95E50Q47575662-35F5621A-FFD4-42D9-917F-06DBFC1025C3Q48116222-A8390B75-6CB0-418B-B844-D1B110CDDD9FQ51672278-930E538D-6527-4B5A-BD0C-D9E5DC38639AQ53635870-702FD86C-4D9C-4BBE-90F4-46EDDB0EF7FEQ61806039-9DE567C6-E77D-4D10-A781-ADE75D77894BQ63285682-96E2F893-71E5-41CD-8965-6F94FD95709AQ64042022-68DF4E25-54E2-43EB-A170-5D939C25B7DEQ64053794-C8396855-4A5C-45E6-B620-629131365F0CQ64084585-73F79990-59B2-4BA8-9514-112785C383E0Q64085270-A0057B3D-198A-4B06-8D17-011CD0A83FDCQ64085690-A1623091-1A34-43AB-9A38-A903B51FCA91Q64101743-B1589BD1-F3E8-498E-AB60-C000581468A0Q64105377-AD3117C4-7950-4F35-B7FF-2EC7E963315BQ64119796-5768AC52-9A10-4161-9BAE-1A89A796DA96Q86077546-8DC4EA6D-6A87-4B4C-A686-C9A494082885
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Pirfenidon
@pl
Pirfenidon
@sh
Pirfenidon
@sr
Pirfenidona
@es
Pirfenidona
@pt
Pirfenidone
@ka
Pirfenidone
@nl
esbriet
@tr
pirfenidon
@nn
pirfenidone
@en
type
label
Pirfenidon
@pl
Pirfenidon
@sh
Pirfenidon
@sr
Pirfenidona
@es
Pirfenidona
@pt
Pirfenidone
@ka
Pirfenidone
@nl
esbriet
@tr
pirfenidon
@nn
pirfenidone
@en
altLabel
AMR 69
@en
AMR-69
@en
Esbriet®
@en
Pirfenidone
@es
prefLabel
Pirfenidon
@pl
Pirfenidon
@sh
Pirfenidon
@sr
Pirfenidona
@es
Pirfenidona
@pt
Pirfenidone
@ka
Pirfenidone
@nl
esbriet
@tr
pirfenidon
@nn
pirfenidone
@en